MedTrace Logo

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

NCT03244826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 404

Last updated 2024-08-16

Study results available
· View outcomes & findings →

Summary

This research study aims to evaluate the effectiveness of allowing patients who have had a hematopoietic cell transplant to receive some of their post-transplant care with a local oncologist rather than returning to the transplant center for all of their follow-up.

Conditions

  • Other Cancer

Interventions

OTHER

Shared Care

Shared Care involves four specific strategies to allow patients to have a portion of their care locally after HCT, where clinic and laboratory visits are equally shared between the local oncologist and primary HCT team

OTHER

Standard Care

The usual care provided by the transplant center at DFCI.

Sponsors & Collaborators

Principal Investigators

  • Gregory A. Abel, MD MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-08-22
Completion
2022-08-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03244826 on ClinicalTrials.gov